CD4 and neoplasm: Overall, our ability to initiate autologous tumor killing by blocking KLRG1’s interactions with E-cadherin nominate KLRG1 not just as a marker of cytotoxic CD4+ T cells with shared tumor specificity, but as an additional regulatory step (separate from PD-1) that can further mobilize killing.